Q4 2025 Earnings Call March 12, 2026 5:00 PM EDTCompany ParticipantsMatt Hopper - Senior VP of Finance & Head of ...

Healthcare data analytics company Health Catalyst (NASDAQ:HCAT) announced in Q4 CY2025, but sales fell by 6.2% year on year to $74.68 million. On the other hand, next quarter’s revenue guidance of $69 ...

Management is not providing 2026 annual guidance at this time. Albert explained, "We plan to come back to the market with our full year revenue and adjusted EBITDA guidance no later than our first ...

Health Catalyst (HCAT) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.04 per share a year ago. These ...

CORAL GABLES, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical ...

Earnings call Health Catalyst reported Q4 2025 revenue of $74.7M (down YoY), with full-year revenue up 1% to $311.1M and Adjusted EBITDA up 59% to $41.4M. Despite strong cost control and margin gains, ...